Rita Rinaldi
Overview
Explore the profile of Rita Rinaldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Vito L, Matteo E, Meletti S, Zenesini C, Bernabe G, Bomprezzi C, et al.
Epilepsia
. 2024 Dec;
66(3):753-767.
PMID: 39707958
Objective: The STEPPER (Status Epilepticus in Emilia-Romagna) study aimed to investigate the clinical characteristics, prognostic factors, and treatment approaches of status epilepticus (SE) in adults of the Emilia-Romagna region (ERR),...
2.
Rossi S, Farina A, Malvaso A, Dinoto A, Fionda L, Cornacchini S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Sep;
11(6):e200314.
PMID: 39298719
Background And Objectives: The clinical course and the risk of chronicity of neurologic immune-related adverse events (n-irAEs) associated with immune checkpoint inhibitors (ICIs) are not well documented. This study aimed...
3.
Viola V, Faini C, Bortolotti C, Guarino M, Cirillo L, Rinaldi R
BMJ Case Rep
. 2024 Aug;
17(8).
PMID: 39159980
Carotid-cavernous fistulas (CCFs) are rare intracranial vascular malformations. Among the various classifications available, the most recently proposed highlights the strong correlation between venous drainage pattern and clinical presentation. We present...
4.
Longhi S, Biagini E, Guaraldi P, Carigi S, Curro Dossi M, Bartolotti M, et al.
J Cardiovasc Med (Hagerstown)
. 2024 Jul;
25(9):682-692.
PMID: 39083075
Aims: Transthyretin cardiac amyloidosis (ATTR-CA) is a rare and progressive cardiomyopathy caused by amyloid fibril deposition in myocardial tissue. Diagnostic challenges have historically hampered timely detection. Recent advances in noninvasive...
5.
Rossi S, Costa R, Di Federico A, Lo Bianco F, DAngelo R, Asioli G, et al.
J Thorac Oncol
. 2024 Jun;
19(9):1352-1355.
PMID: 38912994
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor, is the standard of care for patients with advanced NSCLC and EGFR-sensitizing mutations. Both in osimertinib pivotal trials and in the post-marketing phase,...
6.
Barone V, Foschi M, Pavolucci L, Rondelli F, Rinaldi R, Nicodemo M, et al.
Front Neurol
. 2024 Jun;
15:1407598.
PMID: 38859972
Background And Aims: Fast-track care have been proved to reduce the short-term risk of stroke after transient ischemic attack (TIA). We aimed to investigate stroke risk and to characterize short-...
7.
Rossi S, Rinaldi R, Asioli G, Barone V, Pianta P, Cescon M, et al.
Neurol Sci
. 2024 Mar;
45(7):3107-3115.
PMID: 38460049
Introduction: Tacrolimus-associated neurotoxicity (TAN) manifests with wide clinical spectrum, ranging from mild tremors to severe encephalopathy. The isolated involvement of the brainstem is a rarely documented presentation of TAN, and...
8.
Gramegna L, Rinaldi R, Belotti L, Vignatelli L, Sighinolfi G, Papa V, et al.
Neurol Sci
. 2024 Feb;
45(7):3461-3470.
PMID: 38383748
Purpose: We aim to propose a visual quantitative score for muscle edema in lower limb MRI to contribute to the diagnosis of idiopathic inflammatory myopathy (IIM). Material And Methods: We...
9.
Molinari G, Lucidi D, Fernandez I, Barbazza A, Vanelli E, Lami F, et al.
J Neurol
. 2023 Jul;
270(11):5303-5312.
PMID: 37523065
Objective: To systematically review the published cases of bilateral facial palsy (BFP) to gather evidence on the clinical assessment and management of this pathology. Methods: Following PRISMA statement recommendations, 338...
10.
Raschi E, Rossi S, De Giglio A, Fusaroli M, Burgazzi F, Rinaldi R, et al.
Drug Saf
. 2023 Jun;
46(9):819-833.
PMID: 37341925
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment and care of patients with cancer owing to unique features, including the occurrence of the so-called immune-related adverse events (irAEs). A multidisciplinary...